Synopsis of recent research by authors named "Linda Higgins"
- Linda Higgins' research focuses on enhancing treatment efficacy and safety in chronic conditions, particularly through exploring innovative pharmacological approaches, such as selective PPARγ modulation for type 2 diabetes management and p38 MAPK inhibition for improving cytotoxicity in cancer therapies.
- Her studies also emphasize the importance of quality improvement (QI) in healthcare education, evaluating the success rates of resident and fellow-led QI initiatives, which highlights the need for more robust support and training in this area.
- Additionally, Higgins investigates the impact of technology in nursing environments, assessing how it affects nurses' workflows and patient perceptions, as well as addressing the role of exercise in chronic conditions like cystic fibrosis, aiming to enhance patient adherence and outcomes.